Vessel Health and Preservation: The Right Approach for Vascular Access Nancy L. Moureau Editor Vessel Health and Preservation: The Right Approach for Vascular Access Nancy L. Moureau Editor Vessel Health and Preservation: The Right Approach for Vascular Access Editor Nancy L. Moureau Griffith University Nathan, QLD Australia This book is an open access publication ISBN 978-3-030-03148-0 ISBN 978-3-030-03149-7 (eBook) https://doi.org/10.1007/978-3-030-03149-7 © The Editor(s) (if applicable) and The Author(s) 2019, corrected publication 2019 Open Access This book is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this book are included in the book’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the book’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland Foreword In 2007, clinicians were considering ideas to determine the use of the right line, for the right patient, at the right time. Multiple stakeholders suggested an algorithm would meet the requirement for guiding clinicians in the decision for device selection; however, I believed it did not fully address the ever- changing dynamics of patient-centred vascular access management. As it turned out, there were other clinicians who held the same belief. Communication commenced among industry partners and practising clini- cians and, thus, began a new initiative for reducing healthcare and economic risks associated with vascular access use and delivery of infusion therapies. The proposed initiative was founded upon a philosophy in which a patient’s vasculature and historical use of veins for infusion therapy would be consid- ered and prioritized as a key healthcare objective. This objective required patient-specific vascular access assessment from an emergency department visit through admission, discharge and beyond. The vision for patient-specific vessel health and preservation was clear; however, a defined and measurable process was not. It would take a practising clinical partner who understood not only evidence-based research around infusion therapy but also the practi- cal use of vascular access devices, someone with a documented track record of embracing a vision and turning it into an actionable plan. Enter Nurse Consultant; Nancy L. Moureau. With industry support, an investment com- mitted to the vision allowed Nancy L. Moureau and me to create a foundation for a process which eventually became known as Vessel Health and Preservation (VHP). ‘The Nancy’s’, as we were called, understood driving sustainable change in clinical practice would require a ‘think tank’ of cross-functional key opin- ion leaders, those who were in the vascular access device trenches every day. These selected individuals saw what fragmented and convenience-based device use could do to patients and to their healthcare systems. Thus the ‘G-9’ was formed and included Dr. Thomas Nifong, MD; Cheryl Kelly, RN; Dr. Steve Gordon, MD; Lorelei Papke, RN; Cathy Perry, RN; Dr. Mathew Leavitt, MD; Michael Doll, PA; Connie Biggar, RN; and Jessica Wallace, ARNP. Our working group grew in strength when Dr. Ruth Carrico, RN; Dr. Monte Harvill, MD; Lori Benton, ARNP, PA; and Deborah Phelan, RN, joined in our efforts. In 2012, the working group published a paper describing the VHP approach to vascular access management, summated here as: v vi Foreword Vascular access for the infusion of medications and solutions requires timely assess- ment, planning, insertion, and assessment. Traditional vascular access is reactive, painful, and ineffective, often resulting in the exhaustion of peripheral veins prior to consideration of other access options. Evidence suggests clinical pathways improve outcomes by reducing variations and establishing processes to assess and coordinate care, minimizing fragmentation and cost. Implementation of a vascular access clini- cal pathway leads to the intentional selection of the best vascular access device for the patient specific to the individual diagnosis, treatment plan, current medical con- dition, and the patient’s vessel health. The VHP program incorporates evidence- based practices focused on timely, intentional proactive device selection implemented within 24 hours of admission into any acute facility. VHP is an all- inclusive clinical pathway, guiding clinicians from device selection through patient discharge, inclusive of daily assessment. Initiation of the VHP program within a facility provides a systematic pathway to improve vascular access selection and patient care, allowing for the reduction of variations and roadblocks in care while increasing positive patient outcomes and satisfaction. Patient safety and preserva- tion of vessel health is the ultimate goal. (Moureau N, Trick N, Nifong T, et al. Vessel health and preservation (Part I) approach to vascular access selection and manage- ment. Journal Vascular Access. 2012) Although the entire approach was not immediately adopted by US hospitals, clinicians began talking about the importance of device selection based not only on the immediate need for access but also selection seriously considering the long-term impact on device choice for the patient’s vessel health and efficient provision of treatment. Following publication, the Infection Prevention Society of the United Kingdom expressed interest in the philosophy of VHP. Industry stakeholders again invested in multiple presentations and posters, further pro- moting evidence-based practices in patient-centred vascular access manage- ment. While the US and UK programmes were not mirror images of one another, the philosophy carried over and supported the flexibility to adapt to a healthcare system based on country-specific models of care. Instrumental in this process were Dr. Robert Pratt, PhD; Dr. Heather Loveday, PhD; Carole Hallam, RN; Dr. Tim Jackson, MD; and industry leader Scott Baker. Today, as I reflect on the past 11 years and consider the contents of this book, written by vascular access subject matter experts, it is obvious we hit on an unaddressed clinical need in 2007. An industry partner request for a simple algorithm opened the door to higher thinking and now implementation of many of the evidence-based practices, guidelines, recommendations and processes you will find in this publication. Each author and the editor are to be commended for investing their personal time to define best in class vessel health and preservation. It is now up to you to implement these practices and continue your commitment as a patient advocate. We challenge you to fully understand the foundation of evidence-based and patient-centred vessel health and preservation. Be curious, study, investigate, publish, and push for improvements to vessel health and preservation as it is defined here. Our patients deserve no less! Nancy Trick, RN, CRNI, VA-BC Clinical Market Manager, Worldwide Infusion Disposables Becton, Dickinson The original version of the book was revised: Acknowledgement section text has been updated. The erratum to the book is available at https://doi.org/10.1007/978-3-030-03149-7_23 Acknowledgments Special thanks to 3M, Teleflex and Nancy Trick for making this open-access Vessel Health and Preservation book possible. Without the support and gener- ous offerings of these three we would not have been able to make this infor- mation freely available. Many thanks to these donors and to the supporting associations. This open-access has been possible thanks to the generous contributions of 3M, Teleflex and Nancy Trick. The free access provision would not have happened without the support and generous offerings of these three and the assistance of the Association for Vascular Access Foundation. Many thanks to the donors and supporting associations of the Association for Vascular Access (AVA), the Australian Vascular Access Society (AVAS), Infection Prevention Society (IPS) and the National Infusion and Vascular Access Society (NIVAS) and their contributions to spreading the Vessel Health and Preservation patient safety model. Association for Vascular Access (AVA) and the AVA